首页 > 最新文献

Ageing Research Reviews最新文献

英文 中文
Progress in the mechanisms of pain associated with neurodegenerative diseases 与神经退行性疾病相关的疼痛机制研究取得进展。
IF 12.5 1区 医学 Q1 CELL BIOLOGY Pub Date : 2024-11-13 DOI: 10.1016/j.arr.2024.102579
Zhicheng Tian , Qi Zhang , Ling Wang , Mengxiang Li , Tianjing Li , Yujie Wang , Zixuan Cao , Xiaofan Jiang , Peng Luo
Neurodegenerative diseases (NDDs) represent a class of neurological disorders characterized by the progressive degeneration or loss of neurons, impacting millions of individuals globally. In addition to the typical manifestations, pain is a prevalent symptom associated with NDDs, seriously impacting the quality of life for patients. The pathogenesis of pain associated with NDDs is intricate and multifaceted. Currently, the clinical management of NDDs-related pain symptoms predominantly relies on conventional pharmacological agents or physical therapy. However, these approaches often fail to produce satisfactory outcomes. This article summarizes the underlying mechanisms of major NDDs-associated pain: Neuroinflammation, Brain and spinal cord dysfunctions, Mitochondrial dysfunction, Risk gene and pathological protein, as well as Receptor, channel, and neurotransmitter. While numerous studies have investigated the downstream pathological processes associated with these mechanisms, there remains a significant gap in identifying the key initiating factors. Specifically, there is insufficient evidence for the upstream elements that activate microglia and astrocytes in neuroinflammation leading to pain in NDDs. Likewise, there is an absence of upstream factors elucidating how dysfunctions in the brain and spinal cord, as well as mitochondrial impairments, contribute to the development of pain. Furthermore, the specific mechanisms through which hallmark pathological proteins related to NDDs contribute to these pathological processes remain inadequately understood. The objective of this article is to synthesize the existing mechanisms underlying pain associated with NDDs, including Alzheimer's disease, Parkinson's disease, Huntington's disease, Schizophrenia, Amyotrophic lateral sclerosis, and Multiple sclerosis, while also identifying gaps and deficiencies in these mechanisms. This paper offers insights for future research trajectories. Given the intricate pathogenesis of NDDs-related pain, it emphasizes that a promising short-term strategy is combination therapy—intervening concurrently in multiple pathological processes—akin to the cocktail approach utilized in treating acquired immunodeficiency syndrome (AIDS). For long-term advancements, achieving breakthroughs in the treatment of the NDDs themselves will remain essential for alleviating accompanying pain symptoms.
神经退行性疾病(NDDs)是一类以神经元逐渐退化或丧失为特征的神经系统疾病,影响着全球数百万人。除典型表现外,疼痛也是 NDDs 的常见症状,严重影响患者的生活质量。NDDs 相关疼痛的发病机制错综复杂,涉及多个方面。目前,NDD 相关疼痛症状的临床治疗主要依赖于传统的药物或物理疗法。然而,这些方法往往无法取得令人满意的效果。本文总结了主要 NDDs 相关疼痛的潜在机制:神经炎症、大脑和脊髓功能障碍、线粒体功能障碍、风险基因和病理蛋白,以及受体、通道和神经递质。尽管许多研究都对与这些机制相关的下游病理过程进行了调查,但在确定关键启动因素方面仍存在巨大差距。具体来说,目前还没有足够的证据表明,在神经炎症导致 NDDs 疼痛的过程中,哪些上游因素激活了小胶质细胞和星形胶质细胞。同样,也缺乏上游因素来阐明大脑和脊髓的功能障碍以及线粒体损伤如何导致疼痛的发生。此外,人们对与 NDD 相关的标志性病理蛋白促成这些病理过程的具体机制仍缺乏充分了解。本文旨在综述与阿尔茨海默病、帕金森病、亨廷顿病、精神分裂症、肌萎缩侧索硬化症和多发性硬化症等 NDD 相关的疼痛的现有机制,同时找出这些机制中存在的差距和不足。本文为未来的研究轨迹提供了启示。鉴于 NDD 相关疼痛的发病机制错综复杂,本文强调,一种很有前景的短期策略是联合疗法--同时干预多种病理过程--类似于治疗获得性免疫缺陷综合征(艾滋病)的鸡尾酒疗法。就长期进展而言,在治疗 NDDs 本身方面取得突破对于减轻伴随的疼痛症状仍然至关重要。
{"title":"Progress in the mechanisms of pain associated with neurodegenerative diseases","authors":"Zhicheng Tian ,&nbsp;Qi Zhang ,&nbsp;Ling Wang ,&nbsp;Mengxiang Li ,&nbsp;Tianjing Li ,&nbsp;Yujie Wang ,&nbsp;Zixuan Cao ,&nbsp;Xiaofan Jiang ,&nbsp;Peng Luo","doi":"10.1016/j.arr.2024.102579","DOIUrl":"10.1016/j.arr.2024.102579","url":null,"abstract":"<div><div>Neurodegenerative diseases (NDDs) represent a class of neurological disorders characterized by the progressive degeneration or loss of neurons, impacting millions of individuals globally. In addition to the typical manifestations, pain is a prevalent symptom associated with NDDs, seriously impacting the quality of life for patients. The pathogenesis of pain associated with NDDs is intricate and multifaceted. Currently, the clinical management of NDDs-related pain symptoms predominantly relies on conventional pharmacological agents or physical therapy. However, these approaches often fail to produce satisfactory outcomes. This article summarizes the underlying mechanisms of major NDDs-associated pain: Neuroinflammation, Brain and spinal cord dysfunctions, Mitochondrial dysfunction, Risk gene and pathological protein, as well as Receptor, channel, and neurotransmitter. While numerous studies have investigated the downstream pathological processes associated with these mechanisms, there remains a significant gap in identifying the key initiating factors. Specifically, there is insufficient evidence for the upstream elements that activate microglia and astrocytes in neuroinflammation leading to pain in NDDs. Likewise, there is an absence of upstream factors elucidating how dysfunctions in the brain and spinal cord, as well as mitochondrial impairments, contribute to the development of pain. Furthermore, the specific mechanisms through which hallmark pathological proteins related to NDDs contribute to these pathological processes remain inadequately understood. The objective of this article is to synthesize the existing mechanisms underlying pain associated with NDDs, including Alzheimer's disease, Parkinson's disease, Huntington's disease, Schizophrenia, Amyotrophic lateral sclerosis, and Multiple sclerosis, while also identifying gaps and deficiencies in these mechanisms. This paper offers insights for future research trajectories. Given the intricate pathogenesis of NDDs-related pain, it emphasizes that a promising short-term strategy is combination therapy—intervening concurrently in multiple pathological processes—akin to the cocktail approach utilized in treating acquired immunodeficiency syndrome (AIDS). For long-term advancements, achieving breakthroughs in the treatment of the NDDs themselves will remain essential for alleviating accompanying pain symptoms.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"102 ","pages":"Article 102579"},"PeriodicalIF":12.5,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142634249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer’s disease: A narrative review 阿尔茨海默病中与淀粉样β和 Tau 蛋白失衡有关的非经典途径:叙述性综述。
IF 12.5 1区 医学 Q1 CELL BIOLOGY Pub Date : 2024-11-13 DOI: 10.1016/j.arr.2024.102578
Anna Maggiore , Valentina Latina , Maria D’Erme , Giuseppina Amadoro , Roberto Coccurello
Alzheimer’s Disease (AD) is the most common form of dementia among elderly people. This disease imposes a significant burden on the healthcare system, society, and economy due to the increasing global aging population. Current trials with drugs or bioactive compounds aimed at reducing cerebral Amyloid beta (Aβ) plaques and tau protein neurofibrillary tangles, which are the two main hallmarks of this devastating neurodegenerative disease, have not provided significant results in terms of their neuropathological outcomes nor met the expected clinical end-points. Ageing, genetic and environmental risk factors, along with different clinical symptoms suggest that AD is a complex and heterogeneous disorder with multiple interconnected pathological pathways rather than a single disease entity. In the present review, we highlight and discuss various non-canonical, Aβ-independent mechanisms, like gliosis, unhealthy dietary intake, lipid and sugar signaling, and cerebrovascular damage that contribute to the onset and development of AD. We emphasize that challenging the traditional “amyloid cascade hypothesis” may improve our understanding of this age-related complex syndrome and help fight the progressive cognitive decline in AD.
阿尔茨海默病(AD)是老年人中最常见的痴呆症。由于全球老龄化人口不断增加,这种疾病给医疗保健系统、社会和经济造成了沉重负担。淀粉样 beta(Aβ)斑块和 tau 蛋白神经纤维缠结是这种破坏性神经退行性疾病的两大特征,目前旨在减少这两种疾病的药物或生物活性化合物的试验在神经病理学结果方面没有取得显著效果,也没有达到预期的临床终点。年龄增长、遗传和环境风险因素以及不同的临床症状表明,AD 是一种复杂的异质性疾病,具有多种相互关联的病理途径,而非单一的疾病实体。在本综述中,我们重点讨论了导致 AD 发病和发展的各种非典型的、不依赖于 Aβ 的机制,如神经胶质增生、不健康的饮食摄入、脂质和糖类信号转导以及脑血管损伤。我们强调,挑战传统的 "淀粉样蛋白级联假说 "可能会提高我们对这一与年龄相关的复杂综合征的认识,并有助于对抗注意力缺失症的渐进性认知衰退。
{"title":"Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer’s disease: A narrative review","authors":"Anna Maggiore ,&nbsp;Valentina Latina ,&nbsp;Maria D’Erme ,&nbsp;Giuseppina Amadoro ,&nbsp;Roberto Coccurello","doi":"10.1016/j.arr.2024.102578","DOIUrl":"10.1016/j.arr.2024.102578","url":null,"abstract":"<div><div>Alzheimer’s Disease (AD) is the most common form of dementia among elderly people. This disease imposes a significant burden on the healthcare system, society, and economy due to the increasing global aging population. Current trials with drugs or bioactive compounds aimed at reducing cerebral Amyloid beta (Aβ) plaques and tau protein neurofibrillary tangles, which are the two main hallmarks of this devastating neurodegenerative disease, have not provided significant results in terms of their neuropathological outcomes nor met the expected clinical end-points. Ageing, genetic and environmental risk factors, along with different clinical symptoms suggest that AD is a complex and heterogeneous disorder with multiple interconnected pathological pathways rather than a single disease entity. In the present review, we highlight and discuss various non-canonical, Aβ-independent mechanisms, like gliosis, unhealthy dietary intake, lipid and sugar signaling, and cerebrovascular damage that contribute to the onset and development of AD. We emphasize that challenging the traditional “amyloid cascade hypothesis” may improve our understanding of this age-related complex syndrome and help fight the progressive cognitive decline in AD.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"102 ","pages":"Article 102578"},"PeriodicalIF":12.5,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142634231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current insights and future directions 将线粒体功能障碍作为神经退行性疾病的治疗策略:当前见解与未来方向。
IF 12.5 1区 医学 Q1 CELL BIOLOGY Pub Date : 2024-11-10 DOI: 10.1016/j.arr.2024.102577
Ying-ying Gu , Xin-ru Zhao , Nan Zhang , Yuan Yang , Ying Yi , Qian-hang Shao , Ming-xuan Liu , Xiao-ling Zhang
Neurodegenerative diseases, as common diseases in the elderly, tend to become younger due to environmental changes, social development and other factors. They are mainly characterized by progressive loss or dysfunction of neurons in the central or peripheral nervous system, and common diseases include Parkinson's disease, Alzheimer's disease, Huntington's disease and so on. Mitochondria are important organelles for adenosine triphosphate (ATP) production in the brain. In recent years, a large amount of evidence has shown that mitochondrial dysfunction plays a direct role in neurodegenerative diseases, which is expected to provide new ideas for the treatment of related diseases. This review will summarize the main mechanisms of mitochondrial dysfunction in neurodegenerative diseases, as well as collating recent advances in the study of mitochondrial disorders and new therapies.
神经退行性疾病作为老年人的常见病,受环境变化、社会发展等因素的影响,有年轻化的趋势。主要表现为中枢或周围神经系统神经元进行性丢失或功能障碍,常见疾病包括帕金森病、阿尔茨海默病、亨廷顿病等。线粒体是大脑产生三磷酸腺苷(ATP)的重要细胞器。近年来,大量证据表明线粒体功能障碍在神经退行性疾病中起着直接作用,有望为相关疾病的治疗提供新思路。本综述将总结神经退行性疾病中线粒体功能障碍的主要机制,并整理线粒体疾病研究的最新进展和新疗法。
{"title":"Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current insights and future directions","authors":"Ying-ying Gu ,&nbsp;Xin-ru Zhao ,&nbsp;Nan Zhang ,&nbsp;Yuan Yang ,&nbsp;Ying Yi ,&nbsp;Qian-hang Shao ,&nbsp;Ming-xuan Liu ,&nbsp;Xiao-ling Zhang","doi":"10.1016/j.arr.2024.102577","DOIUrl":"10.1016/j.arr.2024.102577","url":null,"abstract":"<div><div>Neurodegenerative diseases, as common diseases in the elderly, tend to become younger due to environmental changes, social development and other factors. They are mainly characterized by progressive loss or dysfunction of neurons in the central or peripheral nervous system, and common diseases include Parkinson's disease, Alzheimer's disease, Huntington's disease and so on. Mitochondria are important organelles for adenosine triphosphate (ATP) production in the brain. In recent years, a large amount of evidence has shown that mitochondrial dysfunction plays a direct role in neurodegenerative diseases, which is expected to provide new ideas for the treatment of related diseases. This review will summarize the main mechanisms of mitochondrial dysfunction in neurodegenerative diseases, as well as collating recent advances in the study of mitochondrial disorders and new therapies.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"102 ","pages":"Article 102577"},"PeriodicalIF":12.5,"publicationDate":"2024-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142634254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Priorities in tackling noncommunicable diseases among the population aged 60 years and older in China, 1990–2021: A population-based study 1990-2021 年中国 60 岁及以上人口应对非传染性疾病的优先事项:基于人口的研究。
IF 12.5 1区 医学 Q1 CELL BIOLOGY Pub Date : 2024-11-08 DOI: 10.1016/j.arr.2024.102574
Yi Dai , Di Teng , Chengshuo Zhang , Haoyu Wang , Yaxin Lai , Shuangning Ding , Yang Han , Lei Dou , Shize Yang , Yue Ma , Bingyang Liu , Ziyu Gao , Liang He , Xu Han , Guofeng Zhang , Qiaobei Li , Qinghong Zeng , Hangjia Liu , Haoran Zhou , Siyu Wang , Yongze Li

Objective

In China, it is expected that every one in three people will be aged 60 years and above in 2040, surpassing other low- and middle-income countries. The noncommunicable disease (NCD) burden and trends among elderly people must be clarified.

Methods

In this trend analysis based on the Global Burden of Diseases Study 2021, we reported NCDs per 100,000 people and average annual percentage changes (AAPCs) in disability-adjusted life-years (DALYs), mortality, and incidence at three levels of the GBD 2021 hierarchy by age subgroups and by sex in the older population aged 60 years and above in China during 1990–2021.

Results

In 2021, there were 382 million incident cases of NCDs among elderly individuals in China, leading to 201 million DALYs and 9 million deaths in the same year. During 1990–2021, although cardiovascular diseases substantially reduced both DALYs (-1.2 %/year) and mortality (-1.08 %/year), cardiovascular diseases still accounted for the greatest percentage of DALYs (31000 per 100,000 population [95 % UI 26071–35908]) and mortality (2025 [1678–2355]) in 2021. During 1990–2021, while the total incidence of NCDs decreased (-0.01 %/year), the incidence of mental disorders (0.68 %/year) rapidly increased. Among all level 3 causes, depressive disorder caused the greatest increases in DALYs (0.74%/year), while chronic respiratory diseases showed the most rapid decreases in both DALYs (-3.6 %/year) and mortality (-3.6 %/year). The priorities of NCD control in each age subgroup and sex among elderly individuals varied. In 2021, males had a greater DALY rate from NCDs per 100,000 people than females did (96409 [95 % UI 80625–112283] vs. 67112 [56878–77547]), but females had a greater incidence rate of NCDs than males did (150276 [139285–163373]) vs. 137571 [127439–148789]). High systolic blood pressure had surpassed household air pollution from solid fuels as the leading risk factor for DALYs among the elderly, and it continued to be the top risk factor for mortality in this population.

Conclusions

The total NCD burden among elderly people in China has been decreasing and changing. Substantial reductions in cardiovascular diseases and chronic respiratory disease have been observed, while rapid increases in mental disorders has also been found. Policies need to be updated to reflect the changing risk landscape. Target interventions should consider age subgroups and sex differences among this population.
目标:预计到 2040 年,中国每三人中就有一人年龄在 60 岁及以上,超过其他中低收入国家。必须明确老年人的非传染性疾病(NCD)负担和趋势:在这项基于《2021 年全球疾病负担研究》的趋势分析中,我们报告了 1990-2021 年间中国 60 岁及以上老年人口中每 10 万人的非传染性疾病发病率,以及在《2021 年全球疾病负担研究》三个等级中按年龄亚组和性别划分的残疾调整生命年(DALYs)、死亡率和发病率的年均百分比变化(AAPCs):结果:2021 年,中国老年人非传染性疾病的发病数为 3.82 亿例,导致 2.01 亿 DALYs 和 900 万人死亡。1990-2021 年间,虽然心血管疾病大大降低了残疾调整寿命年数(-1.2 %/年)和死亡率(-1.08 %/年),但 2021 年心血管疾病仍占残疾调整寿命年数(31000/10 万人口[95 % UI 26071-35908])和死亡率(2025 [1678-2355])的最大比例。1990-2021 年间,虽然非传染性疾病的总发病率有所下降(-0.01 %/年),但精神障碍的发病率(0.68 %/年)却迅速上升。在所有第 3 级病因中,抑郁障碍导致的残疾调整寿命年数增加最多(0.74%/年),而慢性呼吸道疾病在残疾调整寿命年数(-3.6%/年)和死亡率(-3.6%/年)方面的下降速度最快。每个年龄分组和性别的老年人在非传染性疾病控制方面的优先次序各不相同。2021 年,男性每 100,000 人的非传染性疾病 DALY 率高于女性(96409 [95 % UI 80625-112283] vs. 67112 [56878-77547]),但女性的非传染性疾病发病率高于男性(150276 [139285-163373] vs. 137571 [127439-148789])。高收缩压已超过固体燃料造成的家庭空气污染,成为导致老年人残疾调整寿命年数的首要风险因素,并且仍然是导致该人群死亡的首要风险因素:结论:中国老年人的非传染性疾病总负担一直在下降和变化。结论:中国老年人的非传染性疾病总负担一直在下降和变化,心血管疾病和慢性呼吸系统疾病的负担大幅下降,而精神疾病的负担则迅速上升。政策需要更新,以反映不断变化的风险状况。目标干预措施应考虑到这一人群的年龄分组和性别差异。
{"title":"Priorities in tackling noncommunicable diseases among the population aged 60 years and older in China, 1990–2021: A population-based study","authors":"Yi Dai ,&nbsp;Di Teng ,&nbsp;Chengshuo Zhang ,&nbsp;Haoyu Wang ,&nbsp;Yaxin Lai ,&nbsp;Shuangning Ding ,&nbsp;Yang Han ,&nbsp;Lei Dou ,&nbsp;Shize Yang ,&nbsp;Yue Ma ,&nbsp;Bingyang Liu ,&nbsp;Ziyu Gao ,&nbsp;Liang He ,&nbsp;Xu Han ,&nbsp;Guofeng Zhang ,&nbsp;Qiaobei Li ,&nbsp;Qinghong Zeng ,&nbsp;Hangjia Liu ,&nbsp;Haoran Zhou ,&nbsp;Siyu Wang ,&nbsp;Yongze Li","doi":"10.1016/j.arr.2024.102574","DOIUrl":"10.1016/j.arr.2024.102574","url":null,"abstract":"<div><h3>Objective</h3><div>In China, it is expected that every one in three people will be aged 60 years and above in 2040, surpassing other low- and middle-income countries. The noncommunicable disease (NCD) burden and trends among elderly people must be clarified.</div></div><div><h3>Methods</h3><div>In this trend analysis based on the Global Burden of Diseases Study 2021, we reported NCDs per 100,000 people and average annual percentage changes (AAPCs) in disability-adjusted life-years (DALYs), mortality, and incidence at three levels of the GBD 2021 hierarchy by age subgroups and by sex in the older population aged 60 years and above in China during 1990–2021.</div></div><div><h3>Results</h3><div>In 2021, there were 382 million incident cases of NCDs among elderly individuals in China, leading to 201 million DALYs and 9 million deaths in the same year. During 1990–2021, although cardiovascular diseases substantially reduced both DALYs (-1.2 %/year) and mortality (-1.08 %/year), cardiovascular diseases still accounted for the greatest percentage of DALYs (31000 per 100,000 population [95 % UI 26071–35908]) and mortality (2025 [1678–2355]) in 2021. During 1990–2021, while the total incidence of NCDs decreased (-0.01 %/year), the incidence of mental disorders (0.68 %/year) rapidly increased. Among all level 3 causes, depressive disorder caused the greatest increases in DALYs (0.74%/year), while chronic respiratory diseases showed the most rapid decreases in both DALYs (-3.6 %/year) and mortality (-3.6 %/year). The priorities of NCD control in each age subgroup and sex among elderly individuals varied. In 2021, males had a greater DALY rate from NCDs per 100,000 people than females did (96409 [95 % UI 80625–112283] vs. 67112 [56878–77547]), but females had a greater incidence rate of NCDs than males did (150276 [139285–163373]) vs. 137571 [127439–148789]). High systolic blood pressure had surpassed household air pollution from solid fuels as the leading risk factor for DALYs among the elderly, and it continued to be the top risk factor for mortality in this population.</div></div><div><h3>Conclusions</h3><div>The total NCD burden among elderly people in China has been decreasing and changing. Substantial reductions in cardiovascular diseases and chronic respiratory disease have been observed, while rapid increases in mental disorders has also been found. Policies need to be updated to reflect the changing risk landscape. Target interventions should consider age subgroups and sex differences among this population.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"102 ","pages":"Article 102574"},"PeriodicalIF":12.5,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142634269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron homeostasis and neurodegeneration in the ageing brain: Insight into ferroptosis pathways 老化大脑中的铁稳态和神经退行性变:洞察铁氧化途径。
IF 12.5 1区 医学 Q1 CELL BIOLOGY Pub Date : 2024-11-07 DOI: 10.1016/j.arr.2024.102575
Mohammed Alrouji , Saleha Anwar , Kumar Venkatesan , Moyad Shahwan , Md Imtaiyaz Hassan , Asimul Islam , Anas Shamsi
Ageing is a major risk factor for various chronic diseases and offers a potential target for developing novel and broadly effective preventatives or therapeutics for age-related conditions, including those affecting the brain. Mechanisms contributing to ageing have been summarized as the hallmarks of ageing, with iron imbalance being one of the major factors. Ferroptosis, an iron-mediated lipid peroxidation-induced programmed cell death, has recently been implicated in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD). Addressing ferroptosis offers both opportunities and challenges for treating neurodegenerative diseases, though the specific mechanisms remain unclear. This research explores the key processes behind how ferroptosis contributes to brain ageing, with a focus on the complex signaling networks that are involved. The current article aims to uncover that how ferroptosis, a specific type of cell death, may drive age-related changes in the brain. Additionally, the article also unveils its role in neurodegenerative diseases, discussing how understanding these mechanisms could open up new therapeutic avenues.
老龄化是各种慢性疾病的主要风险因素,也是开发新型、广泛有效的预防或治疗老龄相关疾病(包括影响大脑的疾病)的潜在目标。导致衰老的机制被概括为衰老的标志,而铁失衡是主要因素之一。铁中毒是一种由铁介导的脂质过氧化诱导的程序性细胞死亡,最近被认为与阿尔茨海默病(AD)、帕金森病(PD)和亨廷顿病(HD)等神经退行性疾病有关。尽管具体机制尚不清楚,但解决铁蛋白沉积问题为治疗神经退行性疾病提供了机遇和挑战。这项研究探讨了铁蛋白沉积如何导致大脑老化背后的关键过程,重点是其中涉及的复杂信号网络。这篇文章旨在揭示铁蛋白沉积这种特定类型的细胞死亡是如何驱动大脑中与年龄相关的变化的。此外,文章还揭示了它在神经退行性疾病中的作用,讨论了了解这些机制如何能开辟新的治疗途径。
{"title":"Iron homeostasis and neurodegeneration in the ageing brain: Insight into ferroptosis pathways","authors":"Mohammed Alrouji ,&nbsp;Saleha Anwar ,&nbsp;Kumar Venkatesan ,&nbsp;Moyad Shahwan ,&nbsp;Md Imtaiyaz Hassan ,&nbsp;Asimul Islam ,&nbsp;Anas Shamsi","doi":"10.1016/j.arr.2024.102575","DOIUrl":"10.1016/j.arr.2024.102575","url":null,"abstract":"<div><div>Ageing is a major risk factor for various chronic diseases and offers a potential target for developing novel and broadly effective preventatives or therapeutics for age-related conditions, including those affecting the brain. Mechanisms contributing to ageing have been summarized as the hallmarks of ageing, with iron imbalance being one of the major factors. Ferroptosis, an iron-mediated lipid peroxidation-induced programmed cell death, has recently been implicated in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD). Addressing ferroptosis offers both opportunities and challenges for treating neurodegenerative diseases, though the specific mechanisms remain unclear. This research explores the key processes behind how ferroptosis contributes to brain ageing, with a focus on the complex signaling networks that are involved. The current article aims to uncover that how ferroptosis, a specific type of cell death, may drive age-related changes in the brain. Additionally, the article also unveils its role in neurodegenerative diseases, discussing how understanding these mechanisms could open up new therapeutic avenues.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"102 ","pages":"Article 102575"},"PeriodicalIF":12.5,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142634253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
14–3-3 protein and its isoforms: A common diagnostic marker for Alzheimer’s disease, Parkinson’s disease and glaucomatous neurodegeneration 14-3-3 蛋白质及其同工型:阿尔茨海默病、帕金森病和青光眼神经变性的共同诊断标志物。
IF 12.5 1区 医学 Q1 CELL BIOLOGY Pub Date : 2024-11-01 DOI: 10.1016/j.arr.2024.102572
Siva Prasad Panda , Adarsh Kesharwani , Bhoopendra Singh , Arya Lakshmi Marisetti , MVNL Chaitanya , Saurabh Dahiya , S. Ponnusankar , Sanjesh Kumar , Mansi Singh , Praveen Kumar Shakya , P.Dharani Prasad , Ajay Guru
There is a molecular coupling between neurodegenerative diseases, including glaucomatous neurodegeneration (GN), Alzheimer's disease (AD), and Parkinson's disease (PD). Many cells in the eye and the brain have the right amount of 14–3–3 proteins (14–3–3 s) and their isoforms, such as β, ε, γ, η, θ, π, and γ. These cells include keratocytes, endothelial cells, corneal epithelial cells, and primary conjunctival epithelial cells. 14–3–3 s regulate autophagy and mitophagy, help break down built-up proteins, and connect to other proteins to safeguard against neurodegeneration in AD, PD, GN, and glioblastoma. By interacting with these proteins, 14–3–3 s stop Bad and Bax proteins from entering mitochondria and make them less effective. These interactions inhibit neuronal apoptosis. They play many important roles in managing the breakdown of lysosomal proteins, tau, and Aβ, which is why the 14–3–3 s could be used as therapeutic targets in AD. Furthermore, researchers have discovered 14–3–3 s in Lewy bodies, which are associated with various proteins like LRRK2, ASN, and Parkin, all of which play a role in developing Parkinson's disease (PD). The 14–3–3 s influence the premature aging and natural wrinkles of human skin. Studies have shown that lowering 14–3–3 s in the brain can lead to an increase in cell-death proteins like BAX and ERK, which in turn causes excitotoxicity-induced neurodegeneration. This review aimed to clarify the role of 14–3–3 s in the neuropathology of AD, PD, and GN, as well as potential diagnostic markers for improving neuronal survival and repair.
神经退行性疾病(包括青光眼性神经退行性疾病(GN)、阿尔茨海默病(AD)和帕金森病(PD))之间存在着分子耦合。眼睛和大脑中的许多细胞都含有适量的 14-3-3 蛋白(14-3-3s)及其同工型,如 β、ε、γ、η、θ、π 和 γ。14-3-3s 可调节自噬和有丝分裂,帮助分解积聚的蛋白质,并与其他蛋白质连接,以防止 AD、PD、GN 和胶质母细胞瘤中的神经变性。通过与这些蛋白质相互作用,14-3-3 可阻止 Bad 和 Bax 蛋白进入线粒体,并降低 Bcl-2 的效力。这些相互作用抑制了神经元凋亡。14-3-3s在管理溶酶体蛋白、tau和Aβ的分解方面发挥着许多重要作用,这也是14-3-3s可用作AD治疗靶点的原因。此外,研究人员还在路易体中发现了 14-3-3s,路易体与 LRRK2、ASN 和 Parkin 等多种蛋白质相关,而所有这些蛋白质都在帕金森病(PD)的发病过程中发挥作用。14-3-3s 会影响人体皮肤的早衰和自然皱纹。研究表明,降低大脑中的 14-3-3s 可导致 BAX 和 ERK 等细胞死亡蛋白的增加,进而引起兴奋毒性诱导的神经退行性变。本综述旨在阐明14-3-3s在AD、PD和GN的神经病理学中的作用,以及改善神经元存活和修复的潜在诊断标志物。
{"title":"14–3-3 protein and its isoforms: A common diagnostic marker for Alzheimer’s disease, Parkinson’s disease and glaucomatous neurodegeneration","authors":"Siva Prasad Panda ,&nbsp;Adarsh Kesharwani ,&nbsp;Bhoopendra Singh ,&nbsp;Arya Lakshmi Marisetti ,&nbsp;MVNL Chaitanya ,&nbsp;Saurabh Dahiya ,&nbsp;S. Ponnusankar ,&nbsp;Sanjesh Kumar ,&nbsp;Mansi Singh ,&nbsp;Praveen Kumar Shakya ,&nbsp;P.Dharani Prasad ,&nbsp;Ajay Guru","doi":"10.1016/j.arr.2024.102572","DOIUrl":"10.1016/j.arr.2024.102572","url":null,"abstract":"<div><div>There is a molecular coupling between neurodegenerative diseases, including glaucomatous neurodegeneration (GN), Alzheimer's disease (AD), and Parkinson's disease (PD). Many cells in the eye and the brain have the right amount of 14–3–3 proteins (14–3–3 s) and their isoforms, such as β, ε, γ, η, θ, π, and γ. These cells include keratocytes, endothelial cells, corneal epithelial cells, and primary conjunctival epithelial cells. 14–3–3 s regulate autophagy and mitophagy, help break down built-up proteins, and connect to other proteins to safeguard against neurodegeneration in AD, PD, GN, and glioblastoma. By interacting with these proteins, 14–3–3 s stop Bad and Bax proteins from entering mitochondria and make them less effective. These interactions inhibit neuronal apoptosis. They play many important roles in managing the breakdown of lysosomal proteins, tau, and Aβ, which is why the 14–3–3 s could be used as therapeutic targets in AD. Furthermore, researchers have discovered 14–3–3 s in Lewy bodies, which are associated with various proteins like LRRK2, ASN, and Parkin, all of which play a role in developing Parkinson's disease (PD). The 14–3–3 s influence the premature aging and natural wrinkles of human skin. Studies have shown that lowering 14–3–3 s in the brain can lead to an increase in cell-death proteins like BAX and ERK, which in turn causes excitotoxicity-induced neurodegeneration. This review aimed to clarify the role of 14–3–3 s in the neuropathology of AD, PD, and GN, as well as potential diagnostic markers for improving neuronal survival and repair.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"102 ","pages":"Article 102572"},"PeriodicalIF":12.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut microbiome and Alzheimer’s disease: What we know and what remains to be explored 肠道微生物群与阿尔茨海默病:我们知道什么,还有什么有待探索。
IF 12.5 1区 医学 Q1 CELL BIOLOGY Pub Date : 2024-10-30 DOI: 10.1016/j.arr.2024.102570
Bhupinder Kapoor , Pratim Biswas , Monica Gulati , Pooja Rani , Reena Gupta
With advancement in human microbiome research, an increasing number of scientific evidences have endorsed the key role of gut microbiota in the pathogenesis of Alzheimer disease. Microbiome dysbiosis, characterized by altered diversity and composition, as well as rise of pathobionts influence not only various gut disorder but also central nervous system disorders such as AD. On the basis of accumulated evidences of past few years now it is quite clear that the gut microbiota can control the functions of the central nervous system (CNS) through the gut–brain axis, which provides a new prospective into the interactions between the gut and brain. The main focus of this review is on the molecular mechanism of the crosstalk between the gut microbiota and the brain through the gut–brain axis, and on the onset and development of neurological disorders triggered by the dysbiosis of gut microbiota. Due to microbiota dysbiosis the permeability of the gut and blood brain barrier is increased which may mediate or affect AD. Along with this, bacterial population of the gut microbiota can secrete amyloid proteins and lipopolysaccharides in a large quantity which may create a disturbance in the signaling pathways and the formation of proinflammatory cytokines associated with the pathogenesis of AD. These topics are followed by a critical analysis of potential intervention strategies targeting gut microbiota dysbiosis, including the use of probiotics, prebiotics, metabolites, diets and fecal microbiota transplantation. The main purpose of this review includes the summarization and discussion on the recent finding that may explain the role of the gut microbiota in the development of AD. Understanding of these fundamental mechanisms may provide a new insight into the novel therapeutic strategies for AD.
随着人类微生物组研究的发展,越来越多的科学证据证明肠道微生物群在阿尔茨海默病的发病机制中起着关键作用。以多样性和组成改变为特征的微生物群失调以及病原菌的增加不仅会影响各种肠道疾病,还会影响中枢神经系统疾病,如阿尔茨海默病。过去几年积累的证据表明,肠道微生物群可以通过肠脑轴控制中枢神经系统(CNS)的功能,这为研究肠道与大脑之间的相互作用提供了新的视角。本综述的重点是肠道微生物群通过肠脑轴与大脑之间相互影响的分子机制,以及肠道微生物群失调引发的神经系统疾病的发生和发展。由于微生物群失调,肠道和血脑屏障的通透性增加,这可能会介导或影响注意力缺失症。此外,肠道微生物群中的细菌可大量分泌淀粉样蛋白和脂多糖,这可能会扰乱信号传导途径,并形成与 AD 发病机制相关的促炎细胞因子。在对这些主题进行深入分析后,我们将对针对肠道微生物群失调的潜在干预策略进行批判性分析,包括使用益生菌、益生元、代谢物、饮食和粪便微生物群移植。这篇综述的主要目的包括总结和讨论可能解释肠道微生物群在注意力缺失症发病中作用的最新发现。对这些基本机制的了解可能会为新型 AD 治疗策略提供新的视角。
{"title":"Gut microbiome and Alzheimer’s disease: What we know and what remains to be explored","authors":"Bhupinder Kapoor ,&nbsp;Pratim Biswas ,&nbsp;Monica Gulati ,&nbsp;Pooja Rani ,&nbsp;Reena Gupta","doi":"10.1016/j.arr.2024.102570","DOIUrl":"10.1016/j.arr.2024.102570","url":null,"abstract":"<div><div>With advancement in human microbiome research, an increasing number of scientific evidences have endorsed the key role of gut microbiota in the pathogenesis of Alzheimer disease. Microbiome dysbiosis, characterized by altered diversity and composition, as well as rise of pathobionts influence not only various gut disorder but also central nervous system disorders such as AD. On the basis of accumulated evidences of past few years now it is quite clear that the gut microbiota can control the functions of the central nervous system (CNS) through the gut–brain axis, which provides a new prospective into the interactions between the gut and brain. The main focus of this review is on the molecular mechanism of the crosstalk between the gut microbiota and the brain through the gut–brain axis, and on the onset and development of neurological disorders triggered by the dysbiosis of gut microbiota. Due to microbiota dysbiosis the permeability of the gut and blood brain barrier is increased which may mediate or affect AD. Along with this, bacterial population of the gut microbiota can secrete amyloid proteins and lipopolysaccharides in a large quantity which may create a disturbance in the signaling pathways and the formation of proinflammatory cytokines associated with the pathogenesis of AD. These topics are followed by a critical analysis of potential intervention strategies targeting gut microbiota dysbiosis, including the use of probiotics, prebiotics, metabolites, diets and fecal microbiota transplantation. The main purpose of this review includes the summarization and discussion on the recent finding that may explain the role of the gut microbiota in the development of AD. Understanding of these fundamental mechanisms may provide a new insight into the novel therapeutic strategies for AD.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"102 ","pages":"Article 102570"},"PeriodicalIF":12.5,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aging, brain plasticity, and motor learning 衰老、大脑可塑性和运动学习。
IF 12.5 1区 医学 Q1 CELL BIOLOGY Pub Date : 2024-10-30 DOI: 10.1016/j.arr.2024.102569
Jolien Gooijers , Lisa Pauwels , Melina Hehl , Caroline Seer , Koen Cuypers , Stephan P. Swinnen
Motor skill learning, the process of acquiring new motor skills, is critically important across the lifespan, from early development through adulthood and into older age, as well as in pathological conditions (i.e., rehabilitation). Extensive research has demonstrated that motor skill acquisition in young adults is accompanied by significant neuroplastic changes, including alterations in brain structure (gray and white matter), function (i.e., activity and connectivity), and neurochemistry (i.e., levels of neurotransmitters). In the aging population, motor performance typically declines, characterized by slower and less accurate movements. However, despite these age-related changes, older adults maintain the capacity for skill improvement through training. In this review, we explore the extent to which the aging brain retains the ability to adapt in response to motor learning, specifically whether skill acquisition is accompanied by neural changes. Furthermore, we discuss the associations between inter-individual variability in brain structure and function and the potential for future learning in older adults. Finally, we consider the use of non-invasive brain stimulation techniques aimed at optimizing motor learning in this population. Our review provides insights into the neurobiological underpinnings of motor learning in older adults and emphasizes strategies to enhance their motor skill acquisition.
运动技能学习,即掌握新运动技能的过程,在人的一生中都至关重要,从早期发育到成年,直至老年,以及在病理情况下(即康复)也是如此。大量研究表明,青壮年在掌握运动技能的同时,神经可塑性也会发生显著变化,包括大脑结构(灰质和白质)、功能(即活动和连接性)和神经化学(即神经递质水平)的改变。在老龄人口中,运动能力通常会下降,表现为运动速度变慢、准确性降低。然而,尽管存在这些与年龄相关的变化,老年人仍有能力通过训练提高技能。在这篇综述中,我们将探讨衰老大脑在多大程度上保留了适应运动学习的能力,特别是技能学习是否伴随着神经变化。此外,我们还讨论了大脑结构和功能的个体间差异与老年人未来学习潜力之间的关联。最后,我们还考虑了非侵入性脑刺激技术的使用,旨在优化这一人群的运动学习。我们的综述深入揭示了老年人运动学习的神经生物学基础,并强调了加强老年人运动技能学习的策略。
{"title":"Aging, brain plasticity, and motor learning","authors":"Jolien Gooijers ,&nbsp;Lisa Pauwels ,&nbsp;Melina Hehl ,&nbsp;Caroline Seer ,&nbsp;Koen Cuypers ,&nbsp;Stephan P. Swinnen","doi":"10.1016/j.arr.2024.102569","DOIUrl":"10.1016/j.arr.2024.102569","url":null,"abstract":"<div><div>Motor skill learning, the process of acquiring new motor skills, is critically important across the lifespan, from early development through adulthood and into older age, as well as in pathological conditions (i.e., rehabilitation). Extensive research has demonstrated that motor skill acquisition in young adults is accompanied by significant neuroplastic changes, including alterations in brain structure (gray and white matter), function (i.e., activity and connectivity), and neurochemistry (i.e., levels of neurotransmitters). In the aging population, motor performance typically declines, characterized by slower and less accurate movements. However, despite these age-related changes, older adults maintain the capacity for skill improvement through training. In this review, we explore the extent to which the aging brain retains the ability to adapt in response to motor learning, specifically whether skill acquisition is accompanied by neural changes. Furthermore, we discuss the associations between inter-individual variability in brain structure and function and the potential for future learning in older adults. Finally, we consider the use of non-invasive brain stimulation techniques aimed at optimizing motor learning in this population. Our review provides insights into the neurobiological underpinnings of motor learning in older adults and emphasizes strategies to enhance their motor skill acquisition.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"102 ","pages":"Article 102569"},"PeriodicalIF":12.5,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise-induced adaptive response of different immune organs during ageing 运动诱导不同免疫器官在衰老过程中的适应性反应
IF 12.5 1区 医学 Q1 CELL BIOLOGY Pub Date : 2024-10-30 DOI: 10.1016/j.arr.2024.102573
Huanghao Zhou , Xiao Han , Chunxiu Huang , Huijuan Wu , Yue Hu , Cong Chen , Jing Tao
The immune system plays a crucial role in the ageing process. As individuals age, significant alterations in the immune system experiences occur, marked by a decline in immune cell count, compromised immune function, and decreased immune regulation across various immune organs. These changes collectively weaken the capacity to combat diseases and infections, highlighting the vulnerability that accompanies ageing. Exercise is a potent intervention that profoundly influences holistic well-being and disease mitigation, with a notable emphasis on immune modulation. In general, regular moderate exercise holds significant potential to enhance immune defense mechanisms and metabolic well-being by augmenting the circulation and activation of immune cells. However, some exercise modalities would trigger detrimental effects on the immune system. It can be seen that the regulatory responses of various immune organs to diverse exercise patterns are different. This review aims to examine the immunological responses elicited by exercise across various immune organs, including the lymph nodes, spleen, bone marrow, and thymus, to underscore the nuanced interplay between exercise patterns and the immune organ. This underscores the importance of customizing exercise interventions to optimize immune function across the lifespan.
免疫系统在衰老过程中起着至关重要的作用。随着年龄的增长,免疫系统会发生重大变化,表现为免疫细胞数量减少、免疫功能受损以及各免疫器官的免疫调节能力下降。这些变化共同削弱了人体抵抗疾病和感染的能力,凸显了衰老带来的脆弱性。运动是一种有效的干预措施,能对整体健康和疾病缓解产生深远影响,其中对免疫调节的影响尤为显著。一般来说,经常进行适度的运动可以通过促进免疫细胞的循环和活化来增强免疫防御机制和新陈代谢。不过,有些运动方式会对免疫系统产生不利影响。可见,各种免疫器官对不同运动模式的调节反应是不同的。本综述旨在研究运动在不同免疫器官(包括淋巴结、脾脏、骨髓和胸腺)引起的免疫反应,以强调运动模式与免疫器官之间微妙的相互作用。这强调了定制运动干预措施以优化整个生命周期免疫功能的重要性。
{"title":"Exercise-induced adaptive response of different immune organs during ageing","authors":"Huanghao Zhou ,&nbsp;Xiao Han ,&nbsp;Chunxiu Huang ,&nbsp;Huijuan Wu ,&nbsp;Yue Hu ,&nbsp;Cong Chen ,&nbsp;Jing Tao","doi":"10.1016/j.arr.2024.102573","DOIUrl":"10.1016/j.arr.2024.102573","url":null,"abstract":"<div><div>The immune system plays a crucial role in the ageing process. As individuals age, significant alterations in the immune system experiences occur, marked by a decline in immune cell count, compromised immune function, and decreased immune regulation across various immune organs. These changes collectively weaken the capacity to combat diseases and infections, highlighting the vulnerability that accompanies ageing. Exercise is a potent intervention that profoundly influences holistic well-being and disease mitigation, with a notable emphasis on immune modulation. In general, regular moderate exercise holds significant potential to enhance immune defense mechanisms and metabolic well-being by augmenting the circulation and activation of immune cells. However, some exercise modalities would trigger detrimental effects on the immune system. It can be seen that the regulatory responses of various immune organs to diverse exercise patterns are different. This review aims to examine the immunological responses elicited by exercise across various immune organs, including the lymph nodes, spleen, bone marrow, and thymus, to underscore the nuanced interplay between exercise patterns and the immune organ. This underscores the importance of customizing exercise interventions to optimize immune function across the lifespan.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"102 ","pages":"Article 102573"},"PeriodicalIF":12.5,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142560684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular mechanisms of neurofilament alterations and its application in assessing neurodegenerative disorders 神经丝改变的分子机制及其在评估神经退行性疾病中的应用
IF 12.5 1区 医学 Q1 CELL BIOLOGY Pub Date : 2024-10-29 DOI: 10.1016/j.arr.2024.102566
Shanmukha Sreeya Devarakonda , Shaik Basha , Anjana Pithakumar , Thoshna L B , Darshan Chikkanayakanahalli Mukunda , Jackson Rodrigues , Ameera K , Shimul Biswas , Aparna Ramakrishna Pai , Sushma Belurkar , Krishna Kishore Mahato
Neurofilaments are intermediate filaments present in neurons. These provide structural support and maintain the size and shape of the neurons. Dysregulation, mutation, and aggregation of neurofilaments raise the levels of these proteins in the blood and cerebrospinal fluid (CSF), which are characteristic features of axonal damage and certain rare neurological diseases, such as Giant Axonal Neuropathy and Charcot-Mare-Tooth disease. Understanding the structure, dynamics, and function of neurofilaments has been greatly enhanced by a diverse range of biochemical and preclinical investigations conducted over more than four decades. Recently, there has been a resurgence of interest in post-translational modifications of neurofilaments, such as phosphorylation, aggregation, mutation, oxidation, etc. Over the past twenty years, several rare disorders have been studied from structural alterations of neurofilaments. These disorders are monitored by fluid biomarkers such as neurofilament light chains. Currently, there are many tools, such as Enzyme-Linked Immunosorbent Assay, Electrochemiluminescence Assay, Single-Molecule Array, Western/immunoblotting, etc., in use to assess the neurofilament proteins in Blood and CSF. However, all these techniques utilize expensive, non-specific, or antibody-based methods, which make them unsuitable for routine screening of neurodegenerative disorders. This provides room to search for newer sensitive, cost-effective, point-of-care tools for rapid screening of the disease. For a long time, the molecular mechanisms of neurofilaments have been poorly understood due to insufficient research attempts, and a deeper understanding of them remains elusive. Therefore, this review aims to highlight the available literature on molecular mechanisms of neurofilaments and the function of neurofilaments in axonal transport, axonal conduction, axonal growth, and neurofilament aggregation, respectively. Further, this review discusses the role of neurofilaments as potential biomarkers for the identification of several neurodegenerative diseases in clinical laboratory practice.
神经丝是存在于神经元中的中间丝。它们提供结构支持,维持神经元的大小和形状。神经丝的失调、突变和聚集会提高血液和脑脊液中这些蛋白质的水平,这是轴突损伤和某些罕见神经疾病(如巨轴突性神经病和夏科-马雷-牙病)的特征。四十多年来进行的各种生化和临床前研究大大加深了人们对神经丝的结构、动力学和功能的了解。最近,人们对神经丝翻译后修饰(如磷酸化、聚集、突变、氧化等)的兴趣再次升温。在过去的二十年里,人们从神经丝的结构变化中研究了几种罕见疾病。这些疾病通过神经丝轻链等体液生物标志物进行监测。目前,有许多工具可用于评估血液和脑脊液中的神经丝蛋白,如酶联免疫吸附测定法、电化学发光测定法、单分子阵列法、Western/免疫印迹法等。然而,所有这些技术都采用昂贵、非特异性或基于抗体的方法,因此不适合用于神经退行性疾病的常规筛查。这就为寻找新的、灵敏的、具有成本效益的、用于快速筛查疾病的护理点工具提供了空间。长期以来,由于研究尝试不足,人们对神经丝的分子机制知之甚少,对其更深入的了解仍然遥不可及。因此,本综述旨在重点介绍神经丝的分子机制以及神经丝在轴突运输、轴突传导、轴突生长和神经丝聚集中的功能。此外,本综述还讨论了神经丝在临床实验中作为潜在生物标记物鉴定多种神经退行性疾病的作用。
{"title":"Molecular mechanisms of neurofilament alterations and its application in assessing neurodegenerative disorders","authors":"Shanmukha Sreeya Devarakonda ,&nbsp;Shaik Basha ,&nbsp;Anjana Pithakumar ,&nbsp;Thoshna L B ,&nbsp;Darshan Chikkanayakanahalli Mukunda ,&nbsp;Jackson Rodrigues ,&nbsp;Ameera K ,&nbsp;Shimul Biswas ,&nbsp;Aparna Ramakrishna Pai ,&nbsp;Sushma Belurkar ,&nbsp;Krishna Kishore Mahato","doi":"10.1016/j.arr.2024.102566","DOIUrl":"10.1016/j.arr.2024.102566","url":null,"abstract":"<div><div>Neurofilaments are intermediate filaments present in neurons. These provide structural support and maintain the size and shape of the neurons. Dysregulation, mutation, and aggregation of neurofilaments raise the levels of these proteins in the blood and cerebrospinal fluid (CSF), which are characteristic features of axonal damage and certain rare neurological diseases, such as Giant Axonal Neuropathy and Charcot-Mare-Tooth disease. Understanding the structure, dynamics, and function of neurofilaments has been greatly enhanced by a diverse range of biochemical and preclinical investigations conducted over more than four decades. Recently, there has been a resurgence of interest in post-translational modifications of neurofilaments, such as phosphorylation, aggregation, mutation, oxidation, etc. Over the past twenty years, several rare disorders have been studied from structural alterations of neurofilaments. These disorders are monitored by fluid biomarkers such as neurofilament light chains. Currently, there are many tools, such as Enzyme-Linked Immunosorbent Assay, Electrochemiluminescence Assay, Single-Molecule Array, Western/immunoblotting, etc., in use to assess the neurofilament proteins in Blood and CSF. However, all these techniques utilize expensive, non-specific, or antibody-based methods, which make them unsuitable for routine screening of neurodegenerative disorders. This provides room to search for newer sensitive, cost-effective, point-of-care tools for rapid screening of the disease. For a long time, the molecular mechanisms of neurofilaments have been poorly understood due to insufficient research attempts, and a deeper understanding of them remains elusive. Therefore, this review aims to highlight the available literature on molecular mechanisms of neurofilaments and the function of neurofilaments in axonal transport, axonal conduction, axonal growth, and neurofilament aggregation, respectively. Further, this review discusses the role of neurofilaments as potential biomarkers for the identification of several neurodegenerative diseases in clinical laboratory practice.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"102 ","pages":"Article 102566"},"PeriodicalIF":12.5,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ageing Research Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1